Literature DB >> 28386760

Lung Transplantation in Patients With Systemic Sclerosis.

Rupal J Shah1, Francesco Boin2.   

Abstract

PURPOSE OF REVIEW: The purpose of this study was to highlight recent findings on evaluation for lung transplantation and outcomes after transplantation in patients with systemic sclerosis (scleroderma). RECENT
FINDINGS: The recognition that extra-pulmonary disease manifestations can seriously compromise post-transplant outcomes has changed the way patients are screened for lung transplant candidacy. Reluctance to transplant subjects affected by scleroderma has been driven by the complexity and multisystem nature of this disease. Multiple recent reports provide convincing findings that scleroderma patients undergoing lung transplantation have similar outcomes as those with other non-rheumatologic pulmonary conditions, even when significant esophageal dysmotility is present. New evidence supports the notion that scleroderma should not be a contraindication for referral to lung transplant. Future studies are needed to improve risk stratification, to define protocols for screening and management of extra-pulmonary complications, and to optimize immunosuppression before and after transplant.

Entities:  

Keywords:  Lung transplantation; Outcomes; Systemic sclerosis

Mesh:

Year:  2017        PMID: 28386760     DOI: 10.1007/s11926-017-0650-z

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  61 in total

1.  Disease-related malnutrition in outpatients with systemic sclerosis.

Authors:  Roberto Caporali; Riccardo Caccialanza; Claudia Bonino; Catherine Klersy; Emanuele Cereda; Blerina Xoxi; Anna Crippa; Maria Luisa Rava; Margherita Orlandi; Chiara Bonardi; Barbara Cameletti; Veronica Codullo; Carlomaurizio Montecucco
Journal:  Clin Nutr       Date:  2012-03-13       Impact factor: 7.324

2.  Pre-transplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation.

Authors:  Diana J Kelm; Sara L Bonnes; Michael D Jensen; Patrick W Eiken; Matthew A Hathcock; Walter K Kremers; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2016-02-11       Impact factor: 2.863

3.  Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2008-09       Impact factor: 10.247

4.  OPTN/SRTR 2013 Annual Data Report: liver.

Authors:  W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2015-01       Impact factor: 8.086

5.  Outcomes in systemic sclerosis-related lung disease after lung transplantation.

Authors:  Peter D Sottile; David Iturbe; Tamiko R Katsumoto; M Kari Connolly; Harold R Collard; Lorriana A Leard; Steven Hays; Jeffrey A Golden; Charles Hoopes; Jasleen Kukreja; Jonathan P Singer
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

Review 6.  Scleroderma renal crisis and renal involvement in systemic sclerosis.

Authors:  Thasia G Woodworth; Yossra A Suliman; Wendi Li; Daniel E Furst; Philip Clements
Journal:  Nat Rev Nephrol       Date:  2016-09-19       Impact factor: 28.314

7.  Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study.

Authors:  Szu-Ying Chu; Yi-Ju Chen; Chia-Jen Liu; Wei-Cheng Tseng; Ming-Wei Lin; Chian-Yaw Hwang; Chih-Chiang Chen; Ding-Dar Lee; Tzeng-Ji Chen; Yun-Ting Chang; Wen-Jen Wang; Han-Nan Liu
Journal:  Am J Med       Date:  2013-11       Impact factor: 4.965

8.  Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Authors:  Stephen C Mathai; Laura K Hummers; Hunter C Champion; Fredrick M Wigley; Ari Zaiman; Paul M Hassoun; Reda E Girgis
Journal:  Arthritis Rheum       Date:  2009-02

9.  Gastroesophageal reflux disease in lung transplant recipients.

Authors:  Denis Hadjiliadis; R Duane Davis; Mark P Steele; Robert H Messier; Christine L Lau; Steve S Eubanks; Scott M Palmer
Journal:  Clin Transplant       Date:  2003-08       Impact factor: 2.863

10.  Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience.

Authors:  Catherine H Miele; Kristin Schwab; Rajeev Saggar; Erin Duffy; David Elashoff; Chi-Hong Tseng; Sam Weigt; Deepshikha Charan; Fereidoun Abtin; Jimmy Johannes; Ariss Derhovanessian; Jeffrey Conklin; Kevin Ghassemi; Dinesh Khanna; Osama Siddiqui; Abbas Ardehali; Curtis Hunter; Murray Kwon; Reshma Biniwale; Michelle Lo; Elizabeth Volkmann; David Torres Barba; John A Belperio; David Sayah; Thomas Mahrer; Daniel E Furst; Suzanne Kafaja; Philip Clements; Michael Shino; Aric Gregson; Bernard Kubak; Joseph P Lynch; David Ross; Rajan Saggar
Journal:  Ann Am Thorac Soc       Date:  2016-06
View more
  2 in total

Review 1.  Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact.

Authors:  Mario Naranjo; Paul M Hassoun
Journal:  Diagnostics (Basel)       Date:  2021-05-20

Review 2.  Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.

Authors:  Saja Almaaitah; Kristin B Highland; Adriano R Tonelli
Journal:  Integr Blood Press Control       Date:  2020-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.